Theanine for the treatment of obsessive-compulsive disorder
Phase 2
- Conditions
- Obsessive-compulsive disorder.Obsessive-compulsive disorder
- Registration Number
- IRCT20090117001556N134
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Age between 18 to 60 years
Diagnosis of moderate to severe OCD based on DSM-5
Score of >21 in Yale–Brown obsessive-compulsive scale (Y-BOCS)
Exclusion Criteria
Receiving any treatment up to 6 weeks before the start of the trial
Presence of another psychiatric disorder
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of OCD symptoms. Timepoint: Baseline and weeks 5 and 10. Method of measurement: By Yale–Brown obsessive-compulsive scale (Y-BOCS).
- Secondary Outcome Measures
Name Time Method